The CCL5/CCR5 Axis in Cancer Progression
Tumor cells can “hijack” chemokine networks to support tumor progression. In this context, the C-C chemokine ligand 5/C-C chemokine receptor type 5 (CCL5/CCR5) axis is gaining increasing attention, since abnormal expression and activity of CCL5 and its receptor CCR5 have been found in hematological...
Main Authors: | Donatella Aldinucci, Cinzia Borghese, Naike Casagrande |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/7/1765 |
Similar Items
-
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
by: Donatella Aldinucci, et al.
Published: (2018-05-01) -
Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma
by: Santosh K. Singh, et al.
Published: (2020-04-01) -
Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis
by: Yue Qiu, et al.
Published: (2021-09-01) -
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
by: Suguru Kadomoto, et al.
Published: (2021-08-01) -
CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells
by: Darrin Gao, et al.
Published: (2016-01-01)